Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for osilodrostat (Isturisa) for adult patients with Cushing’s disease who have persistent or recurrent hypercortisolism after primary pituitary surgery and/or irradiation, or for whom pituitary surgery is not an option.